The Risk of Sarcopenia among Adults with Normal-Weight Obesity in a Nutritional Management Setting
Abstract
:1. Introduction
2. Materials and Methods
2.1. Participants and Design of the Study
- 20–39 years: BF% ≥ 39% for females and BF% ≥ 25% for males.
- 40–59 years: BF% ≥ 40% for females and BF% ≥ 28% for males.
- 60–79 years: BF% ≥ 42% for females and BF% ≥ 30% for males.
2.2. Body Weight and Height
2.3. Body Composition
2.4. Statistical Analysis
3. Results
4. Discussion
4.1. Findings and Concordance with Previous Studies
4.2. Potential Clinical Implications and New Directions
4.3. Study Strengths and Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Boutari, C.; Mantzoros, C. A 2022 update on the epidemiology of obesity and a call to action: As its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism 2022, 133, 155217. [Google Scholar] [CrossRef] [PubMed]
- Pi-Sunyer, X. The medical risks of obesity. Postgrad. Med. 2009, 121, 21–33. [Google Scholar] [CrossRef] [PubMed]
- Batsis, J.A.; Zbehlik, A.J.; Barre, L.K.; Bynum, J.P.; Pidgeon, D.; Bartels, S.J. Impact of obesity on disability, function, and physical activity: Data from the Osteoarthritis Initiative. Scand. J. Rheumatol. 2015, 44, 495–502. [Google Scholar] [CrossRef]
- Sarwer, D.B.; Polonsky, H.M. The Psychosocial Burden of Obesity. Endocrinol. Metab. Clin. N. Am. 2016, 45, 677–688. [Google Scholar] [CrossRef] [PubMed]
- Luppino, F.S.; de Wit, L.M.; Bouvy, P.F.; Stijnen, T.; Cuijpers, P.; Penninx, B.W.J.H.; Zitman, F.G. Overweight, obesity, and depression: A systematic review and meta-analysis of longitudinal studies. Arch. Gen. Psychiatry 2010, 67, 220–229. [Google Scholar] [CrossRef]
- Kasen, S.; Cohen, P.; Chen, H.; Must, A. Obesity and psychopathology in women: A three decade prospective study. Int. J. Obes. 2008, 32, 558–566. [Google Scholar] [CrossRef] [Green Version]
- Roberts, R.E.; Deleger, S.; Strawbridge, W.J.; Kaplan, G.A. Prospective association between obesity and depression: Evidence from the Alameda County Study. Int. J. Obes. Relat. Metab. Disord. 2003, 27, 514–521. [Google Scholar] [CrossRef] [Green Version]
- Abdelaal, M.; le Roux, C.W.; Docherty, N.G. Morbidity and mortality associated with obesity. Ann. Transl. Med. 2017, 5, 161. [Google Scholar] [CrossRef] [Green Version]
- Schneider, H.J.; Glaesmer, H.; Klotsche, J.; Böhler, S.; Lehnert, H.; Zeiher, A.M.; März, W.; Pittrow, D.; Stalla, G.K.; Wittchen, H.U. Accuracy of anthropometric indicators of obesity to predict cardiovascular risk. J. Clin. Endocrinol. Metab. 2007, 92, 589–594. [Google Scholar] [CrossRef] [Green Version]
- World Health Organization. Obesity: Preventing and Managing the Global Epidemic; World Health Organization: Geneva, Switzerland, 1998.
- Weir, C.B.; Jan, A. BMI Classification Percentile And Cut Off Points; StatPearls: Treasure Island, FL, USA, 2020. [Google Scholar]
- Pasco, J.A.; Holloway, K.L.; Dobbins, A.G.; Kotowicz, M.A.; Williams, L.J.; Brennan, S.L. Body mass index and measures of body fat for defining obesity and underweight: A cross-sectional, population-based study. BMC Obes. 2014, 1, 9. [Google Scholar] [CrossRef] [PubMed]
- Garn, S.M.; Leonard, W.R.; Hawthorne, V.M. Three limitations of the body mass index. Am. J. Clin. Nutr. 1986, 44, 996–997. [Google Scholar] [CrossRef] [PubMed]
- Franco, L.P.; Morais, C.C.; Cominetti, C. Normal-weight obesity syndrome: Diagnosis, prevalence, and clinical implications. Nutr. Rev. 2016, 74, 558–570. [Google Scholar] [CrossRef] [PubMed]
- De Lorenzo, A.; Del Gobbo, V.; Premrov, M.G.; Bigioni, M.; Galvano, F.; Di Renzo, L. Normal-weight obese syndrome: Early inflammation? Am. J. Clin. Nutr. 2007, 85, 40–45. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- De Lorenzo, A.; Martinoli, R.; Vaia, F.; Di Renzo, L. Normal weight obese (NWO) women: An evaluation of a candidate new syndrome. Nutr. Metab. Cardiovasc. Dis. 2006, 16, 513–523. [Google Scholar] [CrossRef]
- Romero-Corral, A.; Somers, V.K.; Sierra-Johnson, J.; Korenfeld, Y.; Boarin, S.; Korinek, J.; Jensen, M.D.; Parati, G.; Lopez-Jimenez, F. Normal weight obesity: A risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur. Heart J. 2010, 31, 737–746. [Google Scholar] [CrossRef] [PubMed]
- Di Renzo, L.; Noce, A.; De Angelis, S.; Miani, N.; Di Daniele, N.; Tozzo, C.; De Lorenzo, A. Anti-inflammatory effects of combined treatment with acetylsalicylic acid and atorvastatin in hemodialysis patients affected by Normal Weight Obese syndrome. Pharmacol. Res. 2008, 57, 93–99. [Google Scholar] [CrossRef]
- Mohammadian Khonsari, N.; Khashayar, P.; Shahrestanaki, E.; Kelishadi, R.; Mohammadpoor Nami, S.; Heidari-Beni, M.; Esmaeili Abdar, Z.; Tabatabaei-Malazy, O.; Qorbani, M. Normal Weight Obesity and Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis. Front. Endocrinol. 2022, 13, 857930. [Google Scholar] [CrossRef]
- Kreidieh, D.; Itani, L.; El Masri, D.; Tannir, H.; Citarella, R.; El Ghoch, M. Association between Sarcopenic Obesity, Type 2 Diabetes, and Hypertension in Overweight and Obese Treatment-Seeking Adult Women. J. Cardiovasc. Dev. Dis. 2018, 5, 51. [Google Scholar] [CrossRef] [Green Version]
- Khadra, D.; Itani, L.; Tannir, H.; Kreidieh, D.; El Masri, D.; El Ghoch, M. Association between sarcopenic obesity and higher risk of type 2 diabetes in adults: A systematic review and meta-analysis. World J. Diabetes 2019, 10, 311–323. [Google Scholar] [CrossRef]
- Itani, L.; Kreidieh, D.; El Masri, D.; Tannir, H.; El Ghoch, M. The Impact of Sarcopenic Obesity on Health-Related Quality of Life of Treatment-Seeking Patients with Obesity. Curr. Diabetes Rev. 2020, 16, 635–640. [Google Scholar] [CrossRef]
- Di Renzo, L.; Itani, L.; Gualtieri, P.; Pellegrini, M.; El Ghoch, M.; De Lorenzo, A. New BMI Cut-Off Points for Obesity in Middle-Aged and Older Adults in Clinical Nutrition Settings in Italy: A Cross-Sectional Study. Nutrients 2022, 14, 4848. [Google Scholar] [CrossRef] [PubMed]
- Gallagher, D.; Heymsfield, S.B.; Heo, M.; Jebb, S.A.; Murgatroyd, P.R.; Sakamoto, Y. Healthy percentage body fat ranges: An approach for developing guidelines based on body mass index. Am. J. Clin. Nutr. 2000, 72, 694–701. [Google Scholar] [CrossRef] [Green Version]
- Ramírez-Vélez, R.; Correa-Bautista, J.; Sanders-Tordecilla, A.; Ojeda-Pardo, M.L.; Cobo-Mejía, E.A.; Castellanos-Vega, R.d.P.; García-Hermoso, A.; González-Jiménez, E.; Schmidt-Riovalle, J.; González-Ruíz, K. Percentage of body fat and fat mass index as a screening tool for metabolic syndrome prediction in Colombian university students. Nutrients 2017, 9, 1009. [Google Scholar] [CrossRef] [PubMed]
- Correa-Rodríguez, M.; González-Ruíz, K.; Rincón-Pabón, D.; Izquierdo, M.; García-Hermoso, A.; Agostinis-Sobrinho, C.; Sánchez-Capacho, N.; Roa-Cubaque, M.A.; Ramírez-Vélez, R. Normal-Weight Obesity Is Associated with Increased Cardiometabolic Risk in Young Adults. Nutrients 2020, 12, 1106. [Google Scholar] [CrossRef] [Green Version]
- Casadei, K.; Kiel, J. Anthropometric Measurement. In StatPearls [Internet]; StatPearls Publishing: Treasure Island, FL, USA, 2022. [Google Scholar]
- Di Daniele, N.; Petramala, L.; Di Renzo, L.; Sarlo, F.; Della Rocca, D.G.; Rizzo, M.; Fondacaro, V.; Iacopino, L.; Pepine, C.J.; De Lorenzo, A. Body composition changes and cardiometabolic benefits of a balanced Italian Mediterranean Diet in obese patients with metabolic syndrome. Acta Diabetol. 2013, 50, 409–416. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Janssen, I.; Heymsfield, S.B.; Ross, R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J. Am. Geriatr. Soc. 2002, 50, 889–896. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lim, S.; Kim, J.H.; Yoon, J.W.; Kang, S.M.; Choi, S.H.; Park, Y.J.; Kim, K.W.; Lim, J.Y.; Park, K.S.; Jang, H. Sarcopenic obesity: Prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care 2010, 33, 1652–1654. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Coin, A.; Sarti, S.; Ruggiero, E.; Giannini, S.; Pedrazzoni, M.; Minisola, S.; Rossini, M.; Del Puente, A.; Meral Inelmen, E.; Manzato, E.; et al. Prevalence of sarcopenia based on different diagnostic criteria using DEXA and appendicular skeletal muscle mass reference values in an Italian population aged 20 to 80. J. Am. Med. Dir. Assoc. 2013, 14, 507–512. [Google Scholar] [CrossRef]
- Poggiogalle, E.; Lubrano, C.; Sergi, G.; Coin, A.; Gnessi, L.; Mariani, S.; Lenzi, A.; Donini, L. Sarcopenic Obesity and Metabolic Syndrome in Adult Caucasian Subjects. J. Nutr. Health Aging 2016, 20, 958–963. [Google Scholar] [CrossRef]
- Di Renzo, L.; Gratteri, S.; Sarlo, F.; Cabibbo, A.; Colica, C.; De Lorenzo, A. Individually tailored screening of susceptibility to sarcopenia using p53 codon 72 polymorphism, phenotypes, and conventional risk factors. Dis. Markers 2014, 2014, 743634. [Google Scholar] [CrossRef]
- Di Renzo, L.; Sarlo, F.; Petramala, L.; Iacopino, L.; Monteleone, G.; Colica, C.; De Lorenzo, A. Association between -308 G/A TNF-α polymorphism and appendicular skeletal muscle mass index as a marker of sarcopenia in normal weight obese syndrome. Dis. Markers 2013, 35, 615–623. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Di Renzo, L.; Galvano, F.; Orlandi, C.; Bianchi, A.; Di Giacomo, C.; La Fauci, L.; Acquaviva, R.; De Lorenzo, A. Oxidative stress in normal-weight obese syndrome. Obesity 2010, 18, 2125–2130. [Google Scholar] [CrossRef] [PubMed]
- Bano, G.; Trevisan, C.; Carraro, S.; Solmi, M.; Luchini, C.; Stubbs, B.; Manzato, E.; Sergi, G.; Veronese, N. Inflammation and sarcopenia: A systematic review and meta-analysis. Maturitas 2017, 96, 10–15. [Google Scholar] [CrossRef] [PubMed]
- Kalinkovich, A.; Livshits, G. Sarcopenic obesity or obese sarcopenia: A cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Res. Rev. 2017, 35, 200–221. [Google Scholar] [CrossRef]
- Shepherd, J.A.; Ng, B.K.; Sommer, M.J.; Heymsfield, S.B. Body composition by DXA. Bone 2017, 104, 101–105. [Google Scholar] [CrossRef]
- Bredella, M.A.; Ghomi, R.H.; Thomas, B.J.; Torriani, M.; Brick, D.J.; Gerweck, A.V.; Misra, M.; Klibanski, A.; Miller, K. Comparison of DXA and CT in the assessment of body composition in premenopausal women with obesity and anorexia nervosa. Obesity 2010, 18, 2227–2233. [Google Scholar] [CrossRef] [Green Version]
- Donini, L.M.; Busetto, L.; Bischoff, S.C.; Cederholm, T.; Ballesteros-Pomar, M.D.; Batsis, J.A.; Bauer, J.M.; Boirie, Y.; Cruz-Jentoft, A.J.; Dicker, D.; et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Clin. Nutr. 2022, 41, 990–1000. [Google Scholar] [CrossRef]
- Bleeker, S.E.; Moll, H.A.; Steyerberg, E.W.; Donders, A.R.T.; Derksen-Lubsen, G.; Grobbee, D.E.; Moons, K.G.M. External validation is necessary in prediction research: A clinical example. J. Clin. Epidemiol. 2003, 56, 826–832. [Google Scholar] [CrossRef]
Total n = 748 | Males n = 326 | Females n = 422 | |||||
---|---|---|---|---|---|---|---|
NWNO n = 163 | NWO n = 163 | Significance | NWNO n = 211 | NWO n = 211 | Significance | ||
Age | 36.78(12.85) | 36.18(13.51) | 36.82(13.34) | 0.671 | 36.68(12.45) | 37.29(12.38) | 0.613 |
X2 = 0.085; p = 0.959 | X2 = 0.139; p = 0.933 | ||||||
20–39 | 455(60.8) | 104(63.8) | 105(64.4) | 124(58.8) | 122(57.8) | ||
40–59 | 249(33.3) | 45(27.6) | 43(26.4) | 79(37.4) | 82(38.9) | ||
60–79 | 44(5.9) | 14(8.6) | 15(9.2) | 8(3.8) | 7(3.3) | ||
BMI (kg/m2) | 23.40(1.10) | 23.48(1.10) | 23.49(1.13) | 0.94 | 23.28(1.08) | 23.38(1.09) | 0.367 |
BF (kg) | 19.81(5.86) | 11.85(2.78) | 21.67(3.12) | <0.0001 | 18.26(2.62) | 26.07(2.88) | <0.0001 |
BF% | 30.30(9.47) | 16.42 (3.84) | 29.68 (3.25) | <0.0001 | 29.89(3.09) | 41.90(2.16) | <0.0001 |
X2 = 326; p < 0.0001 | X2 = 422; p < 0.0001 | ||||||
NWNO | 374(50.0) | 163(100.0) | 0(0.0) | 211(100.0) | 0(0.0) | ||
NWO | 374(50.0) | 0(0.0) | 163(100.0) | 0(0.0) | 211(0.0) | ||
ASM | 19.97(5.23) | 26.99(3.47) | 22.22(2.90) | <0.0001 | 17.90(2.42) | 14.86(1.73) | <0.0001 |
ASM% | 29.72(5.20) | 37.18(2.71) | 30.40(2.58) | <0.0001 | 29.27(2.19) | 23.89(1.62) | <0.0001 |
Total n = 748 | Males n = 326 | Females n = 422 | |||||
---|---|---|---|---|---|---|---|
NWNO n = 163 | NWO n = 163 | Significance | NWNO n = 211 | NWO n = 211 | Significance | ||
No risk of sarcopenia | 644(86.1) | 162 (99.4) | 140 (85.9) | X2 = 21.77; p < 0.01 | 208(98.6) | 134(63.5) | X2 = 84.46; p < 0.01 |
Risk of Sarcopenia | 104(13.9) | 1 (0.6) | 23 (14.1) | 3 (1.4) | 77 (36.5) |
Males n = 326 | Females n = 422 | |||||
---|---|---|---|---|---|---|
RR | 95%CI | Significance | RR | 95%CI | Significance | |
Age | 1.07 | 1.05–1.09 | <0.00001 | 1.02 | 1.01–1.04 | 0.001 |
BMI | 0.77 | 0.56–1.05 | 0.102 | 1.05 | 0.89–1.23 | 0.573 |
BF% | ||||||
Normal | 1 | 1 | ||||
With obesity | 22.27 | 3.35–147.98 | 0.001 | 25.22 | 8.12–78.36 | <0.0001 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
De Lorenzo, A.; Pellegrini, M.; Gualtieri, P.; Itani, L.; El Ghoch, M.; Di Renzo, L. The Risk of Sarcopenia among Adults with Normal-Weight Obesity in a Nutritional Management Setting. Nutrients 2022, 14, 5295. https://doi.org/10.3390/nu14245295
De Lorenzo A, Pellegrini M, Gualtieri P, Itani L, El Ghoch M, Di Renzo L. The Risk of Sarcopenia among Adults with Normal-Weight Obesity in a Nutritional Management Setting. Nutrients. 2022; 14(24):5295. https://doi.org/10.3390/nu14245295
Chicago/Turabian StyleDe Lorenzo, Antonino, Massimo Pellegrini, Paola Gualtieri, Leila Itani, Marwan El Ghoch, and Laura Di Renzo. 2022. "The Risk of Sarcopenia among Adults with Normal-Weight Obesity in a Nutritional Management Setting" Nutrients 14, no. 24: 5295. https://doi.org/10.3390/nu14245295